Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors

Clinical trial NCT04659603 · TERMINATED

Trial details

NCT number: NCT04659603
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic Pancreatic Carcinoma Metastatic

Start date: 2021-03-29
Primary completion: 2024-02-16
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.